These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20610525)

  • 1. Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient.
    Adabala M; Jhaveri KD; Gitman M
    Nephrol Dial Transplant; 2010 Oct; 25(10):3439-42. PubMed ID: 20610525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide Causing Hyperkalemia: A Case Report and Review of the Literature.
    Sasidharan S; John S; Puri I; Azhar M; Mallappallil M
    Cureus; 2024 Aug; 16(8):e68246. PubMed ID: 39347364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M; Scolnik D; Bentur Y
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B; Boulouffe C; Vanpee D
    Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
    Nakaya M; Oka R; Miyamoto S
    Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-induced hyperkalemia in a patient on maintenance hemodialysis.
    Sharma AM; Thiede HM; Keller F
    Nephron; 1991; 59(3):445-8. PubMed ID: 1684641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
    Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
    Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler.
    Llamado R; Czaja A; Stence N; Davidson J
    J Emerg Med; 2013 Dec; 45(6):e209-13. PubMed ID: 23827165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
    Lheureux PE; Zahir S; Penaloza A; Gris M
    Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide.
    Fleseriu M; Skugor M; Chinnappa P; Siraj ES
    Endocr Pract; 2006; 12(6):635-40. PubMed ID: 17229659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
    Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
    Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the harm associated in treating hyperkalaemia with insulin and dextrose.
    Abou Sherif S; Katsaiti I; Jebb H; Banh S; Bedi R; Levy J; Thomas D; Ashby D; Corbett R
    Clin Med (Lond); 2024 Jul; 24(4):100222. PubMed ID: 38871123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency.
    Verdier M; DeMott JM; Peksa GD
    Aust Crit Care; 2022 May; 35(3):258-263. PubMed ID: 34167889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose.
    Williams PS; Davenport A; Bone JM
    Postgrad Med J; 1988 Jan; 64(747):30-2. PubMed ID: 3047719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.
    Chothia MY; Humphrey T; Schoonees A; Chikte UME; Davids MR
    PLoS One; 2022; 17(5):e0268395. PubMed ID: 35552566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
    Nzerue CM; Thomas J; Volcy J; Edeki T
    Int J Artif Organs; 2003 Jan; 26(1):86-9. PubMed ID: 12602474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.